Updated pharmacotherapy guidance for adult and pediatric patients

The UK HealthCare Pharmacy & Therapeutics Committee has approved the following updates and additions to interim guidance for adult and pediatric patients. New guidelines Interim Guidance for the Use of Tixagevimab-Cilgavimab (Evusheld) in Adult Patients (4-19-22) Interim Guidance for the Use of Tixagevimab-Cilgavimab (Evusheld) in Pediatric Patients (4-22-22) Interim Pharmacotherapy Guidance for SARS-CoV-2 (COVID-19) Infection… Read More